456 related articles for article (PubMed ID: 16557545)
1. Characterization of a hepatitis B and hepatitis delta virus receptor binding site.
Engelke M; Mills K; Seitz S; Simon P; Gripon P; Schnölzer M; Urban S
Hepatology; 2006 Apr; 43(4):750-60. PubMed ID: 16557545
[TBL] [Abstract][Full Text] [Related]
2. Efficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface protein.
Gripon P; Cannie I; Urban S
J Virol; 2005 Feb; 79(3):1613-22. PubMed ID: 15650187
[TBL] [Abstract][Full Text] [Related]
3. Role of the antigenic loop of the hepatitis B virus envelope proteins in infectivity of hepatitis delta virus.
Jaoudé GA; Sureau C
J Virol; 2005 Aug; 79(16):10460-6. PubMed ID: 16051838
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the cytosolic domains of the hepatitis B virus envelope proteins for their function in viral particle assembly and infectivity.
Blanchet M; Sureau C
J Virol; 2006 Dec; 80(24):11935-45. PubMed ID: 17020942
[TBL] [Abstract][Full Text] [Related]
5. Entry of hepatitis delta virus requires the conserved cysteine residues of the hepatitis B virus envelope protein antigenic loop and is blocked by inhibitors of thiol-disulfide exchange.
Abou-Jaoudé G; Sureau C
J Virol; 2007 Dec; 81(23):13057-66. PubMed ID: 17898062
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes.
Ni Y; Lempp FA; Mehrle S; Nkongolo S; Kaufman C; Fälth M; Stindt J; Königer C; Nassal M; Kubitz R; Sültmann H; Urban S
Gastroenterology; 2014 Apr; 146(4):1070-83. PubMed ID: 24361467
[TBL] [Abstract][Full Text] [Related]
7. Myristoylated PreS1-domain of the hepatitis B virus L-protein mediates specific binding to differentiated hepatocytes.
Meier A; Mehrle S; Weiss TS; Mier W; Urban S
Hepatology; 2013 Jul; 58(1):31-42. PubMed ID: 23213046
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the binding of a host cell surface glycoprotein to the preS protein of duck hepatitis B virus.
Ishikawa T; Kuroki K; Lenhoff R; Summers J; Ganem D
Virology; 1994 Aug; 202(2):1061-4. PubMed ID: 8030212
[TBL] [Abstract][Full Text] [Related]
9. Myristoylation signal transfer from the large to the middle or the small HBV envelope protein leads to a loss of HDV particles infectivity.
Abou-Jaoudé G; Molina S; Maurel P; Sureau C
Virology; 2007 Aug; 365(1):204-9. PubMed ID: 17462692
[TBL] [Abstract][Full Text] [Related]
10. Mapping of the hepatitis B virus pre-S1 domain involved in receptor recognition.
Barrera A; Guerra B; Notvall L; Lanford RE
J Virol; 2005 Aug; 79(15):9786-98. PubMed ID: 16014940
[TBL] [Abstract][Full Text] [Related]
11. N-linked glycosylation of hepatitis B surface antigens is involved but not essential in the assembly of hepatitis delta virus.
Wang CJ; Sung SY; Chen DS; Chen PJ
Virology; 1996 Jun; 220(1):28-36. PubMed ID: 8659125
[TBL] [Abstract][Full Text] [Related]
12. Effect of mutations in the small envelope protein of hepatitis B virus on assembly and secretion of hepatitis delta virus.
Jenna S; Sureau C
Virology; 1998 Nov; 251(1):176-86. PubMed ID: 9813213
[TBL] [Abstract][Full Text] [Related]
13. Fine mapping of pre-S sequence requirements for hepatitis B virus large envelope protein-mediated receptor interaction.
Schulze A; Schieck A; Ni Y; Mier W; Urban S
J Virol; 2010 Feb; 84(4):1989-2000. PubMed ID: 20007265
[TBL] [Abstract][Full Text] [Related]
14. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus.
Yan H; Zhong G; Xu G; He W; Jing Z; Gao Z; Huang Y; Qi Y; Peng B; Wang H; Fu L; Song M; Chen P; Gao W; Ren B; Sun Y; Cai T; Feng X; Sui J; Li W
Elife; 2012 Nov; 3():. PubMed ID: 25409679
[TBL] [Abstract][Full Text] [Related]
15. The use of hepatocytes to investigate HDV infection: the HDV/HepaRG model.
Sureau C
Methods Mol Biol; 2010; 640():463-73. PubMed ID: 20645068
[TBL] [Abstract][Full Text] [Related]
16. Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor.
Nkongolo S; Ni Y; Lempp FA; Kaufman C; Lindner T; Esser-Nobis K; Lohmann V; Mier W; Mehrle S; Urban S
J Hepatol; 2014 Apr; 60(4):723-31. PubMed ID: 24295872
[TBL] [Abstract][Full Text] [Related]
17. Strategies to inhibit entry of HBV and HDV into hepatocytes.
Urban S; Bartenschlager R; Kubitz R; Zoulim F
Gastroenterology; 2014 Jul; 147(1):48-64. PubMed ID: 24768844
[TBL] [Abstract][Full Text] [Related]
18. Infectivity determinants of the hepatitis B virus pre-S domain are confined to the N-terminal 75 amino acid residues.
Blanchet M; Sureau C
J Virol; 2007 Jun; 81(11):5841-9. PubMed ID: 17376925
[TBL] [Abstract][Full Text] [Related]
19. A C-terminal PreS1 sequence is sufficient to retain hepatitis B virus L protein in 293 cells.
Gallina A; Gazina E; Milanesi G
Virology; 1995 Oct; 213(1):57-69. PubMed ID: 7483279
[TBL] [Abstract][Full Text] [Related]
20. Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation.
Lütgehetmann M; Mancke LV; Volz T; Helbig M; Allweiss L; Bornscheuer T; Pollok JM; Lohse AW; Petersen J; Urban S; Dandri M
Hepatology; 2012 Mar; 55(3):685-94. PubMed ID: 22031488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
